Pablo Legoretta, Royalty Pharma

Pablo Legoretta is a Managing Director at Royalty Pharma, a prominent venture capital firm located in New York, New York. See contact routes.

About Pablo Legoretta

Pablo Legoretta is a Managing Director at Royalty Pharma, a prominent venture capital firm located in New York, New York. Royalty Pharma stands at the unique intersection of science, medicine, and investing, distinguishing itself as the world's largest buyer of biopharmaceutical royalties. The firm is a leading force in funding innovation across the life sciences sector, holding a substantial global market share exceeding 60%. Since its inception, Royalty Pharma has demonstrated significant financial deployment, investing over $25 billion in capital. This extensive capital allocation has facilitated the completion of more than 80 distinct royalty acquisitions, solidifying its position as a key player in the biopharmaceutical investment landscape.

Pablo Legoretta at a glance

Role
Managing Director
Organization
Royalty Pharma
Location
New York, New York, United States
Investor type
Venture Capital

Frequently asked about Pablo Legoretta

What does Pablo Legoretta invest in?
We have not verified a stated sector or stage focus for Pablo Legoretta at Royalty Pharma (New York, New York, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Pablo Legoretta?
Pablo Legoretta's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Pablo Legoretta based?
Pablo Legoretta is based in New York, New York, United States.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.

Investors similar to Pablo Legoretta (20)

Browse related investor lists (2)

Compare Pablo Legoretta (8)

Investors like Pablo Legoretta · Full investor directory · Investor access · Company funding database